Abstract
Endostatin, a 20 KDa fragment of collagen XVIII, was shown to have an inhibitory effect on angiogenesis and can potentially be used as a tumor growth suppressor. To obtain the amount needed for testing, the protein was successfully cloned and expressed in Pichia pastoris. At the end of the fermentation process, the concentration of the endostatin in the culture was 50 mg per liter, accompanied by 400 gr per liter (wet weight) of biomass. Before the protein can be captured and purified on a packed bed of heparin-Sepharose, the biomass must be removed. Because of the high biomass concentration, conventional biomass removal techniques like centrifugation or filtration are inefficient and cumbersome. Therefore, the expanded-bed adsorption technique was chosen as an alternative approach. An efficient procedure for the initial recovery and purification of the endostatin was developed. The process utilized a cation- exchanger resin instead of a heparin-based affinity resin, because its dynamic capacity was higher, even though it was affected by the high linear flow on the expanded bed. After adjusting the conductivity, pH and biomass concentration, the complete broth was pumped directly on the expanded-bed matrix (Streamline SP XL). Though the yields of protein are similar, the expanded-bed approach is superior to the packed-bed method for several reasons. The expanded-bed process was shorter (only 8 hours compared to 16 hours for the packed bed), it is cheaper, and the product has higher specific activity (29% compared with 18%). Endostatin produced by the expanded-bed adsorption method showed the expected bioactivity and is currently being tested for its potential as a tumor suppressor.
Similar content being viewed by others
References
Boehm T, Pirie-Shepherd S, Trinh LB, Shiloach J and Folkman J (1999) Disruption of the KEX1 gene in Pichia pastoris allows expression of full length murine and human endostatin. Yeast 15: 563-572.
Carlsson J, Janson JC and Sparrman M (1998) Affinity chromatography. In: Janson JC and Ryden L (eds) Protein purification (pp 375-443). Wiley VCH, New York.
Chase HA (1994) Purification of proteins by adsorption chromatography in expanded beds. Trends Biotechnol. 12: 296-303.
Cregg JM, Tschopp JF, Stillman C, Siegel R, Akong M, Craig WS, Buckholtz RG, Madden KR, Kellaris PA, Davis GR, Smiley BL, Cruze J, Torregrossa R, Velicelebi G and Thill GP (1987) High level expression and efficient assembly of hepatitis B surface antigen in the methylotrophic yeast, P. pastoris. Bio/Technology 5: 479-485.
Cunningham BC, Ultsch M, DeVos AM, Mulkerrin MG, Clauser KR, Wells JA (1991) Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254: 821-825.
Dhanabal M, Ramchandran R, Volk R, Stillman IE, Lombardo M, Iruela-Arispe ML, Simons M and Sukhatme VP (1999) Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma. Cancer Res. 59: 189-197.
Holmgren L, O'Reilly MS and Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1: 149-153.
Hsiao J, Ahuluwalia M, Kaufman J, Clem TR and Shiloach J (1992) Adaptive control strategy for maintaining dissolved oxygen concentration in high density growth of recombinant E. coli. Ann NY Acad Sciences 665: 320-333.
Invitrogen Copr, San Diego, CA (1988) A Manual of methods of expression of recombinant proteins in P. pastoris.
Johansson HJ, Jagersten C and Shiloach J (1996) Large scale recovery and purification of periplasmic recombinant protein from E. coli using expanded bed adsorption chromatography followed by new ion exchange media. J. Biotechnol. 48: 9-14.
Kaufman, P, Kubera and Post T (1997) Fermentation: critical process phenomena and new technology developments that affect yield and productivity. Pharmaceut. Engineer. 17: 24-30.
Lin J, Panigraphy D, Trinh LB, Folkman J and Shiloach J (2000) Production process for recombinant human angiostatin in Pichia pastoris. J. Indust. Microbiol. Biotechnol. 24: 31-35.
Park JH, Lee JM and Chung IS (1999) Production of recombinant endostatin from stably transformed Drosophila melanogaster S2 cells. Biotechnol. Lett. 21: 729-733.
O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR and Folkman J (1997) Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285.
Sasaki T, Fukai N, Mann K, Gohring W, Olsen B and Timpl R (1998) Structure, fundation and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiongenesis inhibitor endostatin. EMBO J. 17: 4249-4256.
Slaton JW, Perotte P, Inoue K, Dinney C, Fidler IJ (1999) Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule Clin. Cancer Res. 5: 2726-2734.
Stratton J, Chiruvolu V and Meagher M (1998) High cell density fermentation. In: Higgins DR and Cregg JM (eds) Pichia Protocols (pp 107-120). Humana Press, Toowa, New Jersey.
Wagner LW, Matheson NY, Heisey RF and Schineder K (1997) Use of a silicone tubing sensor to control methanol concentration during fed batch fermentation of P. pastoris. Biotechnol. Tech. 11: 791-795.
Weidner N, Semple JP, Welch WR and Folkman J (1991) Tumor angionensis and metastasis-correlation in invasive breast carcinoma. New England J. Med. 324: 1-8.
Yamaguchi N, Anand-Apte B, Lee M, Sasaki T, Fukai N, Shapiro R, Que I, Lowik C, Timpl R and Olsen B (1999) Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J. 18: 4414-4423.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Trinh, L., Noronha, S.B., Fannon, M. et al. Recovery of mouse endostatin produced by Pichia pastoris using expanded bed adsorption. Bioseparation 9, 223–230 (2000). https://doi.org/10.1023/A:1008133914854
Issue Date:
DOI: https://doi.org/10.1023/A:1008133914854